Category Archives: Pharmacy

Learn To Say No! It's your life, don't let others control it! By: Brandon Hayes … Continue reading →

March 2013 - Best Epic Fail Compilation Like/Share Please 😀 -- Best Fails of the Week 3 Compilation March 2013 Best Fails of the Week 3 Compilation March 2013 Best Fails of the Week 3 Compilation ... By: FailVideosCentral … Continue reading →

RABBIT--LIGI SOO--(OFICIAL VIDEO MARCH 2013) -(HD)1080p Rabbit'Ligi Soo' 1080p HD Video by Enos Olik -like,share the video subscribe to my channel. By: EddieMarxx … Continue reading →

GTC 2013: Opening, TITAN, Simulating Ocean Storms (1 of 11) GTC 2013 kicks off with NVIDIA Co-founder and CEO Jen-Hsun Huang's keynote address. This first segment of his address features the awesome processing power o... By: nvidia … Continue reading →

Harlem SHAKE 35eme promotion de docteurs en pharmacie By: ThePromotion2013 … Continue reading →

CVS Forcing Employees To Reveal Weight or Pay "A new policy at CVS requires all employees who use the company's health care to report their weight, glucose levels, and body fat to their insurer, or pay a... By: TheYoungTurks … Continue reading →

(Reuters) - The U.S. Food and Drug Administration is alerting health care providers that a Georgia compounding pharmacy has recalled all of its sterile products distributed in the United States since October 19, following reports of serious eye infections, the agency said on Thursday. Until further notice, health care providers should stop using all sterile products distributed by Clinical Specialties Compounding and return them to the company, the FDA said. The FDA had previously reported the five cases of serious eye infection from injections of the cancer drug Avastin, which was prepared by Clinical Specialties Compounding Pharmacy (CSCP) to treat the eyesight robbing disease macular degeneration. The drug is not approved for that use, but when cut into doses appropriate for the eye it is substantially cheaper than similar drugs approved for the eye condition. The voluntary recall was expanded beyond Avastin to include all of CSCP's sterile products after the FDA's preliminary findings at the manufacturing site in Augusta, Georgia, raised concerns about a lack of sterility assurance, the agency said. The recall includes dozens of drugs, including antibiotics and numerous eye drugs. "A compromised sterile product puts patients at risk for serious infections," Janet Woodcock, director of the … Continue reading →

WASHINGTON (AP) -- The Food and Drug Administration notified doctors Thursday that a Georgia compounding pharmacy responsible for a drug linked to eye infections has recalled all of its injectable medicines following a federal inspection. Augusta, Ga.-based Clinical Specialties Compounding Pharmacy issued a recall earlier this week on dozens of lots of the Roche drug Avastin after receiving reports of eye infections in five patients treated with the medication. The infections, called endophthalmitis, occur inside the eyeball and can lead to permanent vision loss, the FDA said in a statement. The FDA said Thursday that its inspectors found issues at the pharmacy that raise questions about the sterility of its drugs. The company voluntarily agreed to recall all of its sterile products. The recall includes dozens of drugs, including the antibiotic, vancomycin, and the preterm labor drug, hydroxyprogesterone. Clinical Specialties' lead pharmacist Austin Gore told the Associated Press on Wednesday that the company has processed about 100,000 doses of Avastin since 2005 without any prior incidents. "We're always concerned for the patient, that's the most important thing," Gore said. Avastin is approved for cancer, but many eye doctors prescribe it for macular degeneration, a common vision disorder among older people. … Continue reading →

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/s8pf9f/pharmacy) has announced the addition of the "Pharmacy Automation Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018" report to their offering. This report provides an in-depth analysis and market forecast for the global pharmacy automation market for the period 2012 - 2018. Details are provided of several pharmacy automation devices currently available in the market along with the impact of these machines on modern pharmacies in terms of efficiency, reduction in error and speed. The report also highlights the unique connection of pharmacy automation devices with a number of other markets such as the E-prescription market and its role in the growth of pharmacy automation. The scope of the report includes competitive analysis of major market segments based on end users, technology and of different regional markets such as Europe, North America, Asia-Pacific and the rest of the world. This regional analysis concluded that most developing regions are not yet ready to accept pharmacy automation technology since affordable human skill and low currency value still provides a cheaper work force as compared to mechanization. Along with this, the cost of devices and setting them up is predicted to … Continue reading →

WASHINGTON (AP) -- The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling dozens of lots of the Roche drug Avastin after receiving reports of eye infections among patients. The FDA said Wednesday that Clinical Specialties of Martinez, Ga., has received five reports of eye infections from physicians who used the drug to treat macular degeneration, a common vision disorder in seniors. The compounding pharmacy is recalling 40 lots of Avastin distributed to doctors' offices in Georgia, Louisiana, South Carolina and Indiana since Dec. 18, the FDA said in an online posting. Avastin is approved as a cancer drug, but it is structurally similar to Lucentis, another Roche drug approved for macular degeneration. For years, compounding pharmacies have repackaged Avastin into small vials for use by eye doctors who prescribe it off-label, or without FDA approval. Repackaged injections of Avastin cost about $50, compared with $1,950 for Lucentis. A call placed to Clinical Specialties' lead pharmacist, Austin Gore, was not immediately returned Wednesday. Swiss drugmaker Roche has tried to discourage doctors from using Avastin for such unapproved uses. The company points out that Lucentis was specifically tested and formulated for use in the eye, and its … Continue reading →